Showing results 9 to 22 of 22
< previous
| Preview | Issue Date | Title | Author(s) |
| 2016 | Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol | Calderone, A.; Stevens, W.; Prior, D.; Nandurkar, H.; Gabbay, E.; Proudman, S.; Williams, T.; Celermajer, D.; Sahhar, J.; Wong, P.; Thakkar, V.; Dwyer, N.; Wrobel, J.; Chin, W.; Liew, D.; Staples, M.; Buchbinder, R.; Nikpour, M. |
| 2012 | N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis | Thakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT) |
| 2013 | N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis | Thakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.; Australian Scleroderma Interest Group,; 2012 Annual European Congress of Rheumatology (EULAR) (6 Jun 2012 - 9 Jun 2012 : Berlin, Germany) |
| 2012 | N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study | Thakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Liew, D.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M. |
| 2012 | Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study | Ngian, G.; Stevens, W.; Prior, D.; Gabbay, E.; Roddy, J.; Tran, A.; Minson, R.; Hill, C.; Chow, K.; Sahhar, J.; Proudman, S.; Nikpour, M. |
| 2003 | Pulmonary arterial hypertension: a new era in management | Keogh, A.; McNeil, K.; Williams, T.; Gabbay, E.; Cleland, L. |
| 2015 | Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease | Moore, O.A.; Proudman, S.M.; Goh, N.; Corte, T.J.; Rouse, H.; Hennessy, O.; Morrisroe, K.; Thakkar, V.; Sahhar, J.; Roddy, J.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA) |
| 2013 | Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease | Moore, O.; Proudman, S.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Sahhar, J.; Roddy, J.E.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA) |
| 2010 | Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians | Mangat, P.; Conron, M.; Gabbay, E.; Proudman, S.M. |
| 2013 | Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated? | Nikpour, M.; Stevens, W.; Proudman, S.; Buchbinder, R.; Prior, D.; Zochling, J.; Williams, T.; Gabbay, E.; Nandurkar, H. |
| 2014 | The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis | Morrisroe, K.; Stevens, W.; Nandurkar, H.; Prior, D.; Thakkar, V.; Roddy, J.; Zochling, J.; Sahhar, J.; Tymms, K.; Sturgess, A.; Major, G.; Kermeen, F.; Hill, C.; Walker, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M. |
| 2011 | The Bosentan Patient Registry: long-term survival in pulmonary arterial hypertension | Keogh, A.; Strange, G.; McNeil, K.; Williams, T.; Gabbay, E.; Proudman, S.; Weintraub, R.; Wlodarczyk, J.; Dalton, B. |
| 2013 | The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study | Thakkar, V.; Stevens, W.; Prior, D.; Youssef, P.; Liew, D.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Rischmueller, M.; Proudman, S.; Nikpour, M. |
| 2016 | The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study | Thakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Sahhar, J.; G Walker, J.; Roddy, J.; Lester, S.; Rischmueller, M.; Zochling, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.M.; Nikpour, M. |
